Clinical trials examine molecular classification for GBA1-associated Parkinson's disease, suggesting improved understanding of the condition.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Ziv Gan‐Or (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: